MS4A1 and squamous cell carcinoma: MS4A1 can be used as an immune‐related gene to predict the prognoses of patients with LUAD,33 and the dysregulation of the MS4A1 protein in interstitial lymphocytes may be involved in the progression of asbestos‐related squamous cell carcinoma.34